Official Statements and Press Releases

CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference

CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference CLL Society co-founder and Medical Director... Details

U.S. Food and Drug Administration (FDA) Approves Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

For immediate release, Nov 21. 2019 U.S. Food and Drug Administration (FDA) Approves Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) On... Details